Literature DB >> 31929166

Neuroimaging in Vascular Cognitive Impairment and Dementia: A Systematic Review.

Viviana Frantellizzi1, Arianna Pani2, Maria Ricci3, Nicoletta Locuratolo4, Francesco Fattapposta4, Giuseppe De Vincentis3.   

Abstract

Cerebrovascular diseases are well established causes of cognitive impairment. Different etiologic entities, such as vascular dementia (VaD), vascular cognitive impairment, subcortical (ischemic) VaD, and vascular cognitive disorder, are included in the umbrella definition of vascular cognitive impairment and dementia (VCID). Because of the variability of VCID clinical presentation, there is no agreement on criteria defining the neuropathological threshold of this disorder. In fact, VCID is characterized by cerebral hemodynamic alteration which ranges from decreased cerebral blood flow to small vessels disease and involves a multifactorial process that leads to demyelination and gliosis, including blood-brain barrier disruption, hypoxia, and hypoperfusion, oxidative stress, neuroinflammation and alteration on neurovascular unit coupling, cerebral microbleeds, or superficial siderosis. Numerous criteria for the definition of VaD have been described: the National Institute of Neurological Disorders and Stroke Association Internationale pour Recherche'-et-l'Enseignement en Neurosciences criteria, the State of California Alzheimer's Disease Diagnostic and Treatment Centers criteria, DSM-V criteria, the Diagnostic Criteria for Vascular Cognitive Disorders (a VASCOG Statement), and Vascular Impairment of Cognition Classification Consensus Study. Neuroimaging is fundamental for definition and diagnosis of VCID and should be used to assess the extent, location, and type of vascular lesions. MRI is the most sensible technique, especially if used according to standardized protocols, even if CT plays an important role in several conditions. Functional neuroimaging, in particular functional MRI and PET, may facilitate differential diagnosis among different forms of dementia. This systematic review aims to explore the state of the art and future perspective of non-invasive diagnostics of VCID.

Entities:  

Keywords:  Brain vascular disorders; MRI; PET; functional neuroimaging; neuroimaging; vascular dementia

Mesh:

Year:  2020        PMID: 31929166     DOI: 10.3233/JAD-191046

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  12 in total

1.  Effect of Yisui Multipurpose Soup's Amelioration on D-Galactose-Induced Neuronal Cells.

Authors:  Junfeng Yan; Xia Zhang; Caixian Xiao; Junlu Yi; Qian Chen; Tingliang Gong; Xin Xie; Wenqiang Tao
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-15       Impact factor: 2.650

Review 2.  The Roles of Nitric Oxide Synthase/Nitric Oxide Pathway in the Pathology of Vascular Dementia and Related Therapeutic Approaches.

Authors:  Han-Yan Zhu; Fen-Fang Hong; Shu-Long Yang
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

3.  White matter abnormalities are key components of cerebrovascular disease impacting cognitive decline.

Authors:  Prashanthi Vemuri; Jonathan Graff-Radford; Timothy G Lesnick; Scott A Przybelski; Robert I Reid; Ashritha L Reddy; Val J Lowe; Michelle M Mielke; Mary M Machulda; Ronald C Petersen; David S Knopman; Clifford R Jack
Journal:  Brain Commun       Date:  2021-04-12

Review 4.  Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective.

Authors:  Maria Ricci; Andrea Cimini; Riccardo Camedda; Agostino Chiaravalloti; Orazio Schillaci
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

5.  Cognitive Domain Impairment and All-Cause Mortality in Older Patients Undergoing Hemodialysis.

Authors:  Yidan Guo; Ru Tian; Pengpeng Ye; Xin Li; Guogang Li; Fangping Lu; Yingchun Ma; Yi Sun; Yuzhu Wang; Yuefei Xiao; Qimeng Zhang; Xuefeng Zhao; Haidan Zhao; Yang Luo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-28       Impact factor: 5.555

6.  Exploring the Effect of Enbrel Softgels on PWI Indicators in VCIND Patients.

Authors:  Lei Cui; Pan Li; Jingchen Zhang; Xiaofang Li
Journal:  J Healthc Eng       Date:  2022-04-06       Impact factor: 2.682

7.  Mapping the transcriptomic changes of endothelial compartment in human hippocampus across aging and mild cognitive impairment.

Authors:  Daniel V Guebel; Néstor V Torres; Ángel Acebes
Journal:  Biol Open       Date:  2021-05-17       Impact factor: 2.422

8.  Interactive visualization and analysis of morphological skeletons of brain vasculature networks with VessMorphoVis.

Authors:  Marwan Abdellah; Nadir Román Guerrero; Samuel Lapere; Jay S Coggan; Daniel Keller; Benoit Coste; Snigdha Dagar; Jean-Denis Courcol; Henry Markram; Felix Schürmann
Journal:  Bioinformatics       Date:  2020-07-01       Impact factor: 6.937

Review 9.  Positron Emission Tomography (PET) and Neuroimaging in the Personalized Approach to Neurodegenerative Causes of Dementia.

Authors:  Maria Ricci; Andrea Cimini; Agostino Chiaravalloti; Luca Filippi; Orazio Schillaci
Journal:  Int J Mol Sci       Date:  2020-10-11       Impact factor: 5.923

Review 10.  Retinal biomarkers for Alzheimer's disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis.

Authors:  Cecilia Czakó; Tibor Kovács; Zoltan Ungvari; Anna Csiszar; Andriy Yabluchanskiy; Shannon Conley; Tamas Csipo; Agnes Lipecz; Hajnalka Horváth; Gábor László Sándor; Lilla István; Trevor Logan; Zoltán Zsolt Nagy; Illés Kovács
Journal:  Geroscience       Date:  2020-10-04       Impact factor: 7.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.